Drug Shortage Report for GABAPENTIN
Report ID | 16498 |
Drug Identification Number | 02246314 |
Brand name | GABAPENTIN |
Common or Proper name | GABAPENTIN |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2017-06-15 |
Estimated end date | 2018-04-27 |
Actual end date | 2018-04-27 |
Shortage status | Resolved |
Updated date | 2018-04-30 |
Company comments | Temporarily unavailable |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2018-04-30 | French | Compare |
v8 | 2018-04-30 | English | Compare |
v7 | 2018-04-16 | French | Compare |
v6 | 2018-04-16 | English | Compare |
v5 | 2017-11-06 | French | Compare |
v4 | 2017-11-06 | English | Compare |
v3 | 2017-11-06 | English | Compare |
v2 | 2017-07-19 | French | Compare |
v1 | 2017-07-19 | English | Compare |
Showing 1 to 9 of 9